Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
1352.3000 23.60 (1.78%)
NSE Apr 06, 2026 15:31 PM
Volume: 328.7K
 

1352.30
1.78%
Emkay
DLPL reported a steady Q4, with EBITDA beating street/our estimates by 6% and adj PAT improving 34% on YoY basis. Strong performance in core markets (Delhi NCR), buoyed by network expansion, offset the persistent muted performance of Suburban (mid-single digit revenue growth).
Dr. Lal Pathlabs Ltd. has an average target of 1577.00 from 4 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended